Fact CheckerSign in

NCT07854691Completed

Jacobson's Progressive Muscle Relaxation for Fatigue and Kinesiophobia in Multiple Sclerosis

Changes in Fatigue and Kinesiophobia Following Jacobson's Progressive Muscle Relaxation Technique Among Patients With Multiple Sclerosis: A Quasi-Experimental Study

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

Multiple sclerosis (MS) is a chronic neurological condition that can cause fatigue and fear of movement (kinesiophobia), which may interfere with daily activities and participation in rehabilitation. Jacobson's Progressive Muscle Relaxation Technique (JPMRT) is a structured relaxation technique involving the sequential contraction and relaxation of different muscle groups. This study examined the association between participation in an eight-week JPMRT program and changes in fatigue impact and kinesiophobia among patients with MS. A quasi-experimental, two-group pretest-posttest design was conducted at the Neurological Clinic and Neurological Department of Menoufia University Hospital, Egypt. A total of 70 patients with MS participated in the study. Thirty-five patients were assigned to the control group and 35 to the JPMRT study group using a non-random sequential allocation procedure. The control group was recruited and assessed first, followed by recruitment and intervention of the study group, to reduce the possibility of sharing intervention-related information between participants. Patients in the study group received a structured JPMRT program over eight weeks. The program included four supervised sessions during the first two weeks, followed by six weeks of daily home practice. Each supervised session lasted approximately 30-45 minutes. Participants were taught the correct sequence of contracting and relaxing major muscle groups through demonstration, redemonstration, feedback, educational materials, and instructions for home practice. Home practice was performed once daily for 10-15 minutes. The control group continued to receive routine neurological care without the JPMRT program during the study period. Fatigue impact and kinesiophobia were assessed before and after the eight-week study period using the Modified Fatigue Impact Scale (MFIS) and the Tampa Scale of Kinesiophobia (TSK), respectively. Performance of the relaxation technique was also assessed in the JPMRT group using a performance checklist. The study examined changes in fatigue impact and kinesiophobia within and between the two groups and the relationship between these outcomes after the intervention. Because participants were not randomly allocated and the groups were recruited during different periods, the findings were interpreted as an association rather than definitive evidence of a causal effect of JPMRT.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
27 Sept 2026
Start date
1 Aug 2025
Primary completion date
30 Dec 2025
Lead sponsor
Al-Zaytoonah University of Jordan
NCT number
NCT07854691

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Aug 2025 to the primary completion date, 30 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with a documented psychotic disorder that could impair their ability to understand the study instructions, those who had received psychotherapy during the previous six months, or those who had participated in any program targeting physical health and/or fatigue during the previous six months were excluded.

Who the study is looking for

  • Participants were eligible if they had a diagnosis of multiple sclerosis for at least six months, were aged 20-60 years, and were able to communicate and comprehend the study instructions.

Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Menoufia university
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.